AstraZeneca PLC ADR
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $14,457,000 | $13,588,000 | $14,891,000 | $13,565,000 |
Gross Profit | 11,984,000 | 11,355,000 | 12,166,000 | 10,484,000 |
EBITDA | 4,955,000 | 5,080,000 | 4,432,000 | 4,102,000 |
EBIT | 3,566,000 | 3,796,000 | 2,095,000 | 2,285,000 |
Net Income | 2,450,000 | 2,916,000 | 1,500,000 | 1,429,000 |
Net Change In Cash | 14,457,000 | 13,588,000 | 14,891,000 | 13,565,000 |
Free Cash Flow | 1,463,000 | 3,284,000 | 1,952,000 | 2,025,000 |
Cash | 7,058,000 | 5,230,000 | 5,488,000 | 4,797,000 |
Basic Shares | 3,118,000 | 3,122,000 | 3,124,000 | 3,120,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $54,073,000 | $45,811,000 | $44,351,000 | $37,417,000 |
Gross Profit | 43,866,000 | 37,771,000 | 31,960,000 | 24,980,000 |
EBITDA | 15,438,000 | 13,912,000 | 9,085,000 | 5,113,000 |
EBIT | 10,373,000 | 8,978,000 | 3,831,000 | 1,011,000 |
Net Income | 7,035,000 | 5,955,000 | 3,288,000 | 112,000 |
Net Change In Cash | 54,073,000 | 45,811,000 | 44,351,000 | 37,417,000 |
Free Cash Flow | 7,275,000 | 6,567,000 | 7,237,000 | 3,763,000 |
Cash | 5,488,000 | 5,840,000 | 6,166,000 | 6,329,000 |
Basic Shares | 3,126,000 | 1,562,000 | 3,120,000 | 2,854,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.79 |
2025-03-31 | $1.25 |
2024-12-31 | $1.05 |
